These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Homocysteine and cognitive impairment in Parkinson's disease]. Martín-Fernández JJ; Carles-Díes R; Cañizares F; Parra S; Avilés F; Villegas I; Morsi-Hassan O; Fernández-Barreiro A; Herrero MT Rev Neurol; 2010 Feb 1-15; 50(3):145-51. PubMed ID: 20146187 [TBL] [Abstract][Full Text] [Related]
7. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. Rogers JD; Sanchez-Saffon A; Frol AB; Diaz-Arrastia R Arch Neurol; 2003 Jan; 60(1):59-64. PubMed ID: 12533089 [TBL] [Abstract][Full Text] [Related]
8. Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients. Camicioli RM; Bouchard TP; Somerville MJ Mov Disord; 2009 Jan; 24(2):176-82. PubMed ID: 18951534 [TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration. Lamberti P; Zoccolella S; Armenise E; Lamberti SV; Fraddosio A; de Mari M; Iliceto G; Livrea P Eur J Neurol; 2005 May; 12(5):365-8. PubMed ID: 15804266 [TBL] [Abstract][Full Text] [Related]
10. Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson's disease patients: A randomized controlled study. Anamnart C; Kitjarak R J Clin Neurosci; 2021 Jun; 88():226-231. PubMed ID: 33992189 [TBL] [Abstract][Full Text] [Related]
11. Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients. Lamberti P; Zoccolella S; Iliceto G; Armenise E; Fraddosio A; de Mari M; Livrea P Mov Disord; 2005 Jan; 20(1):69-72. PubMed ID: 15390046 [TBL] [Abstract][Full Text] [Related]
12. Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients. Caccamo D; Gorgone G; Currò M; Parisi G; Di Iorio W; Menichetti C; Belcastro V; Parnetti L; Rossi A; Pisani F; Ientile R; Calabresi P Neuromolecular Med; 2007; 9(3):249-54. PubMed ID: 17914182 [TBL] [Abstract][Full Text] [Related]
15. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital. Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818 [TBL] [Abstract][Full Text] [Related]
16. [Treatment with levodopa can affect latent vitamin B 12 and folic acid deficiency. Patients with Parkinson disease runt the risk of elevated homocysteine levels]. Lökk J Lakartidningen; 2003 Aug; 100(35):2674-7. PubMed ID: 14531126 [TBL] [Abstract][Full Text] [Related]